Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$150k
1 round on record
Latest round
$150k
Convertible Note · Sep 2025 · 13 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
13 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Convertible Note | Sep 2025 | $150k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Nivalon Medical Technologies Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Todd HodrinskyExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Who is Jassby? Jassby is a fintech company focusing on the card issuing industry.

Adventris Pharmaceuticals is a biotechnology company focusing on cancer immunotherapy.

High impact solutions for patients.. Companies Founded.

Refr Health helps patients get the care they need, faster. We connect hundreds of patients to GP referrals and Medicare funding across…

Increase efficiency, reduce administrative burden, and achieve faster turnaround times while focusing on what’s most important: optimizing…

TailorCare empowers patients to make the best treatment plans for their unique joint, back, and muscle pain.
Overview
We are Patient Driven. Focusing on each patient to provide personalized.
People

Todd Hodrinsky
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Financials
Total raised
$150k
Latest round
Convertible Note
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Convertible Note | 2025 | $150k | Details |





